"Smack it..."

"Baobabababababa..."

The scholars on the scene gave Zhou Wenbao the warmest applause, which was a huge difference from the sparse applause at the beginning.

Zhou Wen expressed his gratitude several times and nodded to the audience, and they all received warm applause again.

Three times later, the applause finally disappeared slowly.

Zhou Wen said slowly: "As we all know, unlike healthy cells, cancer cells are constantly dividing, and new DNA and RNA are needed to support the production of new cells.

But after our unremitting research, early lung cancer has unexpected weaknesses, especially relying on the pyrimidine biosynthesis pathway, and a drug we call lanthanase can effectively resist it in cell lines and mouse models…”

With Zhou Wen's remarks, thousands of lung cancer experts and scholars in the audience gradually showed surprise on their faces.

"With more in-depth research, we have made breakthrough progress in the treatment of early stage lung cancer!"

After pausing, as the experts at the audience held their breath and concentrated, Zhou Wen said: "Using this weakness, we have successfully resisted the invasion of early lung cancer and further effectively killed it."

As Zhou Wen spoke, the big screen behind him lit up, and an experimental data diagram appeared on it.

Zhou Wen lowered his head and slid the iPad on the podium, and the data map on the large screen also moved left and right.

"Code name DST-104, this is the first simulation experiment three months ago, mainly targeting the more common mutant genes EGFR, ALK, cMET, ROS1, HER2, KRAS, etc... This is the second animal experiment two months ago..."

With Zhou Wen's explanation, the scene was silent at the beginning, but gradually became boiling.

Countless experts and scholars began to discuss it loudly.

"Didn't Dr. Aung Naing say that the reaction effect is not good if he uses anti-PD-1 monoclonal antibody alone, why is his reaction the opposite?"

"Hey, look, the gene sequence of this dihydroorotate dehydrogenase has changed."

"Why is the reaction of this lanthanase agent so strange..."

The experimental data released by Zhou Wen was like throwing a huge rock under the calm lake, instantly causing huge waves.

The discussions among lung cancer experts on the scene were getting louder and louder.

Although those medical professionals who do not have a thorough understanding of lung cancer, representatives of pharmaceutical companies, and patients who attend lung cancer who do not understand the complex theoretical knowledge and target maps, they understand Zhou Wen's words - early lung cancer can be completely cured.

"What he said is true? Early stage lung cancer can be completely cured?"

"It's impossible, there was no news before."

"This person is the winner of the Gelderner Award, so he shouldn't be talking nonsense..."

Wu Yilong, who was sitting in the middle, was also extremely surprised at this time.

He had been speculating before that how could Zhou Wen, a person who studies biological viruses, appear at the lung cancer conference? He didn't expect that the other party would really make a breakthrough in the field of lung cancer research.

"Teacher, how true is this data?" asked the assistant sitting next to Wu Yilong.

Wu Yilong looked at the experimental data on the big screen in a moment, and said in a solemn tone: "It's not certain yet, it's necessary to do an experiment to know."

After pausing for a half second, Wu Yilong said, "But this person is a medical genius and has achieved brilliant achievements in oncology. It is very likely that it is true."

The assistant looked at the data on the big screen and showed a look of shock on his face.

His teacher has been studying lung tumors for twenty years. Although he has achieved outstanding results, most of them are based on foreign research results.

Like Zhou Wen, who directly breaks through early lung cancer, especially small-cell lung cancer, which accounts for 15% of the total lung cancer, has high malignancy and limited treatment measures. So far, there are no approved targeted drugs in the world.

Zhou Wen actually announced that he could be cured, which was simply scary.

Moreover, since it has a curative effect on early stage lung cancer, it means that it will definitely have a very obvious therapeutic effect on medium- and advanced stage lung cancer.

How come this doesn't shock you?

The buzzing sound at the scene became louder and louder.

Especially those tumors and lung tumor experts, there were a lot of questions at this time, but Zhou Wen had already walked off the podium.

The host Ronald, after whispering with the people beside him, said: "Ahem... First of all, thank you Professor Zhou Wen for the wonderful speech you gave to everyone. Just now, Dr. Taylor and Professor Nicholas said that they would leave you with ten minutes of time to ask questions. Professor Zhou, please see..."

Zhou Wen, who had just walked to the seat, smiled and said, "Okay..."

...

The news that early lung cancer was conquered was unexpectedly quickly entered the mainstream media in major countries around the world, including Stars, China, France, Italy, Germany, Russia, etc.

Soon the United States, the United Kingdom, South Korea, Australia, New Zealand and other countries also reported one after another.

Privately, countless lung tumor research institutes and pharmaceutical companies in Western countries were surprised and shocked after learning the news.

In terms of tumor treatment, Western research institutes have always been at the forefront of the world. Every year, they rely on medical agent authorization to earn tens of billions of dollars in profits from China.

But unexpectedly, this time, Chinese pharmaceutical companies took the lead in producing research results.

The European and American pharmaceutical giants were a little surprised at first, but when they saw Zhou Wen's name, the look of surprise on their faces quickly returned to normal.

These pharmaceutical giants have a more thorough understanding of Zhou Wen.

In addition to increasing the development of new drugs, they also conducted more in-depth commercial investigations on Zhou Wen and Huanyu Biopharma.

On October 13, Huanyu Bio held its first press conference at the Jiangzhou Taihu International Conference Center.

He mainly answered questions from reporters on HIV-specific drugs, new anti-sensitivity drugs, new lung cancer drugs, etc.

More than 1,600 journalists from more than 70 countries around the world attended the press conference.

For the first time, Universal Bio has come from behind the scenes to the forefront.

The press conference will be broadcast live.

Luo Zongwei, vice president and director of marketing operations department of Universal Biologics, answered more than 60 questions raised by reporters.

Many people have learned about the scientific research strength of the world for the first time.

For example, in its laboratory, there are an astonishing number of researchers with doctoral degrees, and more than 1,500 graduates from key universities.

"Our scientific research investment is also very huge. In the first half of 2020, the staff salary expenditure alone reached 750 million, and the experimental funding exceeded 2 billion."

"With such a waste of money, the output is naturally very gratifying."

"For example, the biological ointments that have just been launched have very good therapeutic effects on various skin diseases. For example, ichthyosis, folliculitis, scleroderma, and psoriasis, etc., have been verified."

“There are also…”

Taking advantage of the press conference, Luo Zongwei also seized the opportunity to promote the company's products...

The spotlights flashed at the press conference, and major pharmaceutical companies at home and abroad have basically paid attention to the press conference.

Pfizer, Novartis, Roche, Match, Sanofi, Gunshot, Gilead Science, GlaxoSmithKline, AbbVie, Amgen, AstraZeneca, Allergan, etc.

Domestic people like Hengrui, Mairui, Yaoming Kant, Ali Health, Yunnan Pharmaceutical, Hengda Health, Sinopharm Holdings, Zhifei Bio, Yaoming Bio, Shiyao Group, etc.

The previous scientific research results made these company executives and shareholders envious and jealous.

And their talent reserves also make many domestic companies feel inferior.

Of course they know that doctoral students are good, and students who graduate from key universities are smart, so the key is that they can’t afford to hire them.

A doctoral student has to pay at least 200,000 to 300,000 yuan per year?

How many ten?

How many are one hundred?

In addition, how much salary does a master's and undergraduate student from key universities have to pay in a year?

All these are money!

There are also experimental consumables, etc.

Such a huge investment in scientific research is only comparable to those large domestic pharmaceutical companies.

However, when Luo Zongwei talked about scientific research output, many people disdained and despised him.

This is pure nonsense.

They acknowledge that pharmaceuticals are high-input and high-output industries.

However, there is a problem here: pharmaceuticals do not pay off by investment.

If this is true, domestic capital would have flocked to it long ago, so how could it be that all of them would be engaged in real estate?

...

Huanyu Bio has shown its strength and has surprised many domestic pharmaceutical companies.

Villa No. 108, Jiangnan Garden, basketball room.

Zhou Wen stood outside the three-point line and patted the basketball gently, staring at the live broadcast of the press conference on the wall.

"Pong-Pong-Pong-Pong-"

When warm applause sounded at the press conference, he smiled and threw it away. The basketball drew a graceful arc and fell into the basket.

The basketball did not roll out of the line or bounce to another place as I imagined, but bounced on the ground a few times and happened to fall into Zhou Wen's hands.

Zhou Wen slapped a few times, then threw it into the basket again, and then bounced into his arms again as if he had eyes.

Then he leaned over slightly, and after doing a few extremely sexy fancy dribbles like the All-Star Game on TV, he rushed forward and raised his body more than three meters high, and most of his body had already exceeded the basket.
To be continued...